CA1087617A - Phenyl piperazines - Google Patents

Phenyl piperazines

Info

Publication number
CA1087617A
CA1087617A CA275,160A CA275160A CA1087617A CA 1087617 A CA1087617 A CA 1087617A CA 275160 A CA275160 A CA 275160A CA 1087617 A CA1087617 A CA 1087617A
Authority
CA
Canada
Prior art keywords
formula
piperazine
compound
phenyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA275,160A
Other languages
English (en)
Inventor
John P. Verge
William B. Jamieson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Application granted granted Critical
Publication of CA1087617A publication Critical patent/CA1087617A/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CA275,160A 1976-04-23 1977-03-30 Phenyl piperazines Expired CA1087617A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines
GB16526/76 1976-04-23

Publications (1)

Publication Number Publication Date
CA1087617A true CA1087617A (fr) 1980-10-14

Family

ID=10078930

Family Applications (1)

Application Number Title Priority Date Filing Date
CA275,160A Expired CA1087617A (fr) 1976-04-23 1977-03-30 Phenyl piperazines

Country Status (34)

Country Link
JP (1) JPS52151183A (fr)
AR (2) AR222003A1 (fr)
AT (1) AT355579B (fr)
AU (1) AU514822B2 (fr)
BE (1) BE853899A (fr)
BG (2) BG28055A3 (fr)
CA (1) CA1087617A (fr)
CH (2) CH625802A5 (fr)
CS (1) CS196360B2 (fr)
DD (1) DD129790A5 (fr)
DE (1) DE2717415A1 (fr)
DK (1) DK176177A (fr)
ES (2) ES457988A1 (fr)
FI (1) FI63937C (fr)
FR (1) FR2348925A1 (fr)
GB (1) GB1575904A (fr)
GR (1) GR64084B (fr)
HU (1) HU176820B (fr)
IE (1) IE44730B1 (fr)
IL (1) IL51787A (fr)
LU (1) LU77170A1 (fr)
MX (1) MX4596E (fr)
NL (1) NL7704456A (fr)
NO (1) NO146710C (fr)
NZ (1) NZ183715A (fr)
OA (1) OA05643A (fr)
PH (1) PH14124A (fr)
PL (1) PL117466B1 (fr)
PT (1) PT66452B (fr)
RO (1) RO72831A (fr)
SE (1) SE7704536L (fr)
SU (2) SU664564A3 (fr)
YU (1) YU104477A (fr)
ZA (1) ZA771849B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Polyazofarbstoffe
JPH07157477A (ja) * 1993-12-02 1995-06-20 Asahi Kagaku Kogyo Kk チアゾール誘導体の製造方法
MX9603998A (es) * 1994-03-11 1997-12-31 Yamanouchi Pharma Co Ltd Agonista receptor de 5-ht3, derivado de tiazol novedoso e intermediario del mismo.
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
ES2462240T3 (es) 2006-02-28 2014-05-22 Dart Neuroscience (Cayman) Ltd Piperazinas terapéuticas como inhibidores de PDE4

Also Published As

Publication number Publication date
PL117466B1 (en) 1981-08-31
FI63937B (fi) 1983-05-31
NL7704456A (nl) 1977-10-25
SU664564A3 (ru) 1979-05-25
JPS52151183A (en) 1977-12-15
PH14124A (en) 1981-02-26
NO771398L (no) 1977-10-25
HU176820B (en) 1981-05-28
IL51787A (en) 1980-02-29
SE7704536L (sv) 1977-10-24
CS196360B2 (en) 1980-03-31
BG27746A3 (en) 1979-12-12
OA05643A (fr) 1981-04-30
ATA285177A (de) 1979-08-15
MX4596E (es) 1982-06-25
AU2438677A (en) 1978-10-26
CH633009A5 (en) 1982-11-15
AR222003A1 (es) 1981-04-15
RO72831A (fr) 1983-08-03
LU77170A1 (fr) 1979-01-18
DK176177A (da) 1977-10-24
BE853899A (fr) 1977-10-24
RO72831B (ro) 1983-07-30
PT66452B (en) 1979-03-09
FI771287A (fr) 1977-10-24
PL197550A1 (pl) 1979-05-21
IL51787A0 (en) 1977-05-31
GB1575904A (en) 1980-10-01
GR64084B (en) 1980-01-21
FI63937C (fi) 1983-09-12
CH625802A5 (en) 1981-10-15
BG28055A3 (en) 1980-02-25
SU727146A3 (ru) 1980-04-05
ES457988A1 (es) 1978-07-16
AR222635A1 (es) 1981-06-15
ZA771849B (en) 1978-11-29
YU104477A (en) 1983-01-21
IE44730L (en) 1977-10-23
DE2717415A1 (de) 1977-11-10
PT66452A (en) 1977-05-01
AT355579B (de) 1980-03-10
DD129790A5 (de) 1978-02-08
NO146710C (no) 1982-11-24
FR2348925A1 (fr) 1977-11-18
IE44730B1 (en) 1982-03-10
AU514822B2 (en) 1981-02-26
NZ183715A (en) 1980-04-28
FR2348925B1 (fr) 1980-04-11
NO146710B (no) 1982-08-16
ES467948A1 (es) 1978-11-01

Similar Documents

Publication Publication Date Title
US6114334A (en) Piperazine derivatives as therapeutic agents
US4233302A (en) Amine derivatives and pharmaceutical compositions containing them
US4279819A (en) Aminoalkyl furan derivatives
EP0183191B1 (fr) Dérivés de thiénylthiazole
US4764612A (en) 3-[3-[1-piperidinylmethyl]phenoxy]propanamine
DK149023B (da) Analogifremgangsmaade til fremstilling af tiazolidinderivater
US4123529A (en) Phenylpiperazine derivatives
US4490369A (en) Benzazepine derivatives, their pharmaceutical compositions and method of use
JPS6312069B2 (fr)
CZ20013736A3 (cs) Derivát karbamové kyseliny a jeho pouľití jako metabotropních glutamátových receptorových ligandů
US4442116A (en) Heterocyclic compounds
CA1087617A (fr) Phenyl piperazines
US4672063A (en) Antiallergic 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-one compounds
CA1082181A (fr) Derives de la benzamide
CA1158649A (fr) Amino-triazoles substitues
Maduskuie et al. Design, synthesis, and structure-activity relationship studies for a new imidazole series of J774 macrophage specific acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors
EP0016565B1 (fr) Dérivés du triazole-1,2,4, procédés pour leur préparation et compositions pharmaceutiques les contenant
US3183229A (en) Hydrazones derived from 1-amino-4-diphenylalkylpiperazines and heterocyclic aldehydes and ketones
EP0455356A1 (fr) 5-Amino-1,2,4,-thiadiazoles substituÀ©s à activité pharmaceutique
US4935424A (en) 4 or 5-(substituted piperazinylalkyl)-2-aminothiazoles as antipsychotic agents
US4062844A (en) Process for preparing hypotensive 2-(4-aroylpiperazin-1-yl)-amino-6,7-dimethoxyquinazolines
US4382929A (en) Thiophene derivatives and their pharmaceutical compositions and method of use
US4169855A (en) N'-derivatives of n-(2-mercapto-ethyl)-2-nitro-1,1-ethenediamine
US6284775B1 (en) 3-[4-(1-substituted-4-piperazinyl)butyl]-4-thiazolidinone and related compounds
US3154557A (en) 2[omega-(2- and 4-pyridyl)-lower-alkoxy]tetrahydropyrans and compounds prepared therefrom

Legal Events

Date Code Title Description
MKEX Expiry